Aquestive Therapeutics, Inc. (AQST)

NASDAQ: AQST · Real-Time Price · USD

3.830

-0.050 (-1.29%)

At close: Feb 18, 2026, 4:00 PM EST

3.820

-0.010 (-0.26%)

After-hours: Feb 18, 2026, 7:54 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2006
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '06 Dec 31, 2006
Pharmaceuticals	57.56M	50.58M	47.68M	50.83M	45.85M
Pharmaceuticals Growth	13.80%	6.09%	-6.20%	10.87%	-12.85%
Total	57.56M	50.58M	47.68M	50.83M	45.85M
Total Growth	13.80%	6.09%	-6.20%	10.87%	-12.85%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2006
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '06 Dec 31, 2006
United States	39.93M	37.10M	40.79M	42.86M	40.96M
United States Growth	7.62%	-9.04%	-4.83%	4.65%	-15.19%
Ex-United States	17.63M	13.48M	6.89M	7.97M	4.89M
Ex-United States Growth	30.80%	95.69%	-13.60%	62.93%	13.37%
Total	57.56M	50.58M	47.68M	50.83M	45.85M
Total Growth	13.80%	6.09%	-6.20%	10.87%	-12.85%

Source: S&P Global Market Intelligence.